{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T03:44:30Z","timestamp":1789184670798,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K16147"],"award-info":[{"award-number":["22K16147"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jjcc.2025.08.007","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T06:48:48Z","timestamp":1755845328000},"page":"238-245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Chronic kidney disease and contemporary guideline-directed medical therapy during hospitalization in patients with heart failure: Insights from PRE-UPFRONT-HF"],"prefix":"10.1016","volume":"87","author":[{"given":"Yudai","family":"Fujimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kitai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Horiuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Murai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuichi","family":"Matsukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuro","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Jujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayane","family":"Kanai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Matsue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2025.08.007_bb0005","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/HHF.0b013e318291329a","article-title":"Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association","volume":"6","author":"Heidenreich","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jjcc.2025.08.007_bb0010","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1253\/circj.CJ-23-0350","article-title":"Management and outcomes of acute heart failure hospitalizations in Japan","volume":"88","author":"Kanaoka","year":"2024","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2025.08.007_bb0015","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.008687","article-title":"9-year trend in the management of acute heart failure in Japan: a report from the national consortium of acute heart failure registries","volume":"7","author":"Shiraishi","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jjcc.2025.08.007_bb0020","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jjcc.2023.10.009","article-title":"Heart failure management guidelines: new recommendations and implementation","volume":"83","author":"Heidenreich","year":"2024","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2025.08.007_bb0025","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1253\/circj.CJ-23-0356","article-title":"Initiation and up-titration of guideline-based medications in hospitalized acute heart failure patients \u2013 a report from the West Tokyo Heart Failure Registry","volume":"88","author":"Ohata","year":"2023","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2025.08.007_bb0030","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ejhf.2333","volume":"24","author":"Authors\/Task Force Members","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jjcc.2025.08.007_bb0035","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2025.08.007_bb0040","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1253\/circj.CJ-25-0002","article-title":"JCS\/JHFS 2025 guideline on diagnosis and treatment of heart failure","volume":"89","author":"Kitai","year":"2025","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2025.08.007_bb0045","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/ejhf.3267","article-title":"Contemporary guideline-directed medical therapy in de novo, chronic, and worsening heart failure patients: first data from the TITRATE-HF study","volume":"26","author":"Malgie","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jjcc.2025.08.007_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchf.2022.08.009","article-title":"Heart failure drug treatment-inertia, titration, and discontinuation: a multinational observational study (EVOLUTION HF)","volume":"11","author":"Savarese","year":"2023","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jjcc.2025.08.007_bb0055","doi-asserted-by":"crossref","first-page":"e1008","DOI":"10.1016\/S2214-109X(18)30306-1","article-title":"Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study","volume":"6","author":"Teng","year":"2018","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.jjcc.2025.08.007_bb0060","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jjcc.2023.07.019","article-title":"Implementation of evidence-based heart failure management: regional variations between Japan and the USA","volume":"83","author":"Ichihara","year":"2024","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2025.08.007_bb0065","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1161\/01.CIR.0000116764.53225.A9","article-title":"Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study","volume":"109","author":"McAlister","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2025.08.007_bb0070","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jacc.2018.04.070","article-title":"Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF registry","volume":"72","author":"Greene","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2025.08.007_bb0075","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.hlc.2023.12.013","article-title":"Efficacy of guideline-directed medical therapy in heart failure patients with and without chronic kidney disease: a meta-analysis of 63,677 patients","volume":"33","author":"Clark","year":"2024","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.jjcc.2025.08.007_bb0080","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/ejhf.1697","article-title":"Evaluation of kidney function throughout the heart failure trajectory - a position statement from the Heart Failure Association of the European Society of Cardiology","volume":"22","author":"Mullens","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jjcc.2025.08.007_bb0085","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jacc.2021.05.002","article-title":"Kidney function and outcomes in patients hospitalized with heart failure","volume":"78","author":"Patel","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2025.08.007_bb0090","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1253\/circj.CJ-24-1020","volume":"89","author":"Fujimoto","year":"2025","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2025.08.007_bb0095","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/01.CIR.88.1.107","article-title":"Survival after the onset of congestive heart failure in Framingham Heart Study subjects","volume":"88","author":"Ho","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2025.08.007_bb0100","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.jacc.2011.11.066","article-title":"Estimated glomerular filtration rate and prognosis in heart failure: value of the Modification of Diet in Renal Disease Study-4, chronic kidney disease epidemiology collaboration, and Cockroft-Gault formulas","volume":"59","author":"Zamora","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2025.08.007_bb0105","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1161\/CIRCULATIONAHA.120.047480","article-title":"Effect of dapagliflozin on outpatient worsening of patients with heart failure and reduced ejection fraction: a prespecified analysis of DAPA-HF","volume":"142","author":"Docherty","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2025.08.007_bb0110","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jacc.2022.11.023","article-title":"Worsening heart failure: nomenclature, epidemiology, and future directions: JACC review topic of the week","volume":"81","author":"Greene","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2025.08.007_bb0115","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jacc.2021.11.033","article-title":"Optimal background pharmacological therapy for heart failure patients in clinical trials: JACC review topic of the week","volume":"79","author":"Fiuzat","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2025.08.007_bb0120","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1002\/ehf2.14524","article-title":"A scoring evaluation for the practical introduction of guideline-directed medical therapy in heart failure patients","volume":"10","author":"Matsukawa","year":"2023","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jjcc.2025.08.007_bb0125","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1253\/circj.CJ-24-0265","article-title":"Optimizing guideline-directed medical therapy during hospitalization improves prognosis in patients with worsening heart failure requiring readmissions","volume":"88","author":"Matsukawa","year":"2024","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2025.08.007_bb0130","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1253\/circj.CJ-19-0342","article-title":"JCS 2017\/JHFS 2017 guideline on diagnosis and treatment of acute and chronic heart failure \u2013 digest version","volume":"83","author":"Tsutsui","year":"2019","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2025.08.007_bb0135","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijcard.2015.08.187","article-title":"Ahead score--long-term risk classification in acute heart failure","volume":"202","author":"Spinar","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jjcc.2025.08.007_bb0140","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004297","article-title":"Performance of AHEAD score in an Asian cohort of acute heart failure with either preserved or reduced left ventricular systolic function","volume":"6","author":"Chen","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jjcc.2025.08.007_bb0145","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.121.008351","article-title":"Diuretic changes, health care resource utilization, and clinical outcomes for heart failure with reduced ejection fraction: from the change the management of patients with heart failure registry","volume":"14","author":"Khan","year":"2021","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jjcc.2025.08.007_bb0150","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2025.08.007_bb0155","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2025.08.007_bb0160","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2025.08.007_bb0165","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2025.08.007_bb0170","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N Engl J Med"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508725002114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508725002114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T05:29:29Z","timestamp":1772861369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0914508725002114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0914508725002114"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2025.08.007","relation":{},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic kidney disease and contemporary guideline-directed medical therapy during hospitalization in patients with heart failure: Insights from PRE-UPFRONT-HF","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2025.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Japanese College of Cardiology. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}